Showing 1,523 results

Filters Content type: News, Editors' picks Topic: Pharmaceutical industry

News and information on drug companies, the cost of therapies, patent protections and generic medicines.

Pharmaceutical industry

BioCryst scoops up early-stage Hep C drugs in $101M Presidio acquisition

Editor's pick
FierceBiotech
18 October 2012
New & experimental hepatitis C treatment

A New And Interesting Addition To The Hep C Clinical Pipeline

Editor's pick
Seeking Alpha
18 October 2012
Pharmaceutical industry

GlaxoSmithKline To Make Clinical Trial Data Available To Other Researchers

Editor's pick
Kaiser Daily Global Health Policy Report
15 October 2012
Pharmaceutical industry

Tanzania investigates fake HIV drugs

Editor's pick
BBC News
12 October 2012
Access to healthcare

Indonesia in bold move to obtain cheap drugs for HIV

Editor's pick
The Guardian
12 October 2012
Bad science & bogus treatments

Tanzania: Factory Closed Over Fake Ante-Retrovirals

Editor's pick
allAfrica.com
11 October 2012
TB transmission & prevention

Aeras signs agreement with GSK to jointly advance TB vaccine

Editor's pick
Eurekalert Medicine & Health
10 October 2012
The search for a cure

Could Sangamo's 'functional cure' for HIV disrupt the drug market?

Editor's pick
MarketWatch (blog)
5 October 2012
Access to healthcare

MSF launches online resource for challenging unwarranted drug patents

Editor's pick
Médecins Sans Frontières press release
3 October 2012
Access to healthcare

Intellectual Property Policy Incoherence at the African Union Threatens Access to Medicines – Proposed Pan-African IP Organization a Terrible Idea

Editor's pick
Fix the Patent Laws
2 October 2012
Pharmaceutical industry

The drugs don't work: a modern medical scandal

Editor's pick
The Guardian
25 September 2012
Finance & funding

Pharma Money in an Election Year

Editor's pick
Pharmalot
21 September 2012
New & experimental hepatitis C treatment

Simeprevir (TMC435) and TMC647055 Interferon Free Combination Hepatitis C Trial Will Commence Shortly

Editor's pick
Medivir press release
21 September 2012
Pharmaceutical industry

Boehringer Ingelheim exits virology research as hep C drugs move down pipeline

Editor's pick
Pharma Times
20 September 2012
New & experimental HIV treatments

Avexa’s HIV integrase inhibitors show activity against drug-resistant HIV with potential for once-daily dosing

Editor's pick
Avexa press release
20 September 2012
New & experimental hepatitis C treatment

Medgenics' Bulging Pipeline Of Blockbuster Indications Takes On Big Pharma's Harmful Drugs

Editor's pick
Seeking Alpha
19 September 2012
Pharmaceutical industry

Gilead's HIV pill could be market leader in 3-5 years: JP Morgan

Editor's pick
CNBC
18 September 2012
Access to healthcare

Gilead Sciences, Task Force Agree to ADAP Price Discount for Stribild

Editor's pick
AIDSMeds.com
10 September 2012
Side effects

Salix Says FDA Decision Delayed on HIV-Associated Diarrhea Drug

Editor's pick
Bloomberg
6 September 2012
Pharmaceutical industry

High-End HIV Drug Stribild To Set Gilead Sciences Apart

Editor's pick
Seeking Alpha
6 September 2012
Drug-resistant TB

Janssen-Cilag International NV (Janssen) Submits European Marketing Authorisation Application for Investigational Multi-Drug Resistant Tuberculosis Treatment Bedaquiline

Editor's pick
Janssen-Cilag press release
3 September 2012
New & experimental hepatitis C treatment

Achillion Deal Looming as Hepatitis Drugs Fail: Real M&A

Editor's pick
Business Week
30 August 2012
Pharmaceutical industry

Quad approved in US: exorbitant cost likely to block use in Europe

Editor's pick
HIV i-Base
28 August 2012
New & experimental HIV treatments

F.D.A. Approves Once-a-Day Pill for H.I.V.

Editor's pick
New York Times
28 August 2012